Specialties

Chronic kidney disease is a risk factor for peripheral artery disease (PAD)—a common but often undetected condition causing reduced blood flow in the legs.

Duloxetine was linked with modest changes in glycemia in patients with diabetic peripheral neuropathic pain (DPNP), according to the results of 3 randomized trials.

For those lucky few who make it to the century mark, a crucial gene variation relating to HDL cholesterol levels may play an important part in their longevity.

More aggressive screening and treatment is needed in children with type 2 diabetes to prevent complications as they get older.

A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, scientists report.

For older people with diabetes, the condition does not increase the likelihood that they’ll develop Alzheimer’s disease, according to a report in the medical journal Neurology.

A new cardiovascular drug screening has identified existing anti-hypertensive agents capable of preventing cognitive decline and amyloid neuropathology associated with Alzheimer’s disease.

Treatment of new-onset type 1 diabetes with peptide is safe and associated with preserved beta-cell function.

Researchers have used cells from human bone marrow to repair damaged pancreatic beta cells in mice. The study offers hopes that these stem cells could be used to treat diabetes in humans. The stem cells also halted damage to the kidneys caused by diabetes.

Having type 2 diabetes may have one benefit, in that men with long-term diabetes may have a reduced risk of prostate cancer, according to the results of a study published in the American Journal of Epidemiology.